Page last updated: 2024-11-08

aspartic acid and Memory Disorders

aspartic acid has been researched along with Memory Disorders in 28 studies

Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.

Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (10.71)18.2507
2000's14 (50.00)29.6817
2010's9 (32.14)24.3611
2020's2 (7.14)2.80

Authors

AuthorsStudies
Wang, X1
Gao, H1
Zhang, X1
Qian, S1
Wang, C1
Deng, L1
Zhong, M1
Qing, G1
Lombardo, B1
Pagani, M1
De Rosa, A1
Nunziato, M1
Migliarini, S1
Garofalo, M1
Terrile, M1
D'Argenio, V1
Galbusera, A1
Nuzzo, T1
Ranieri, A1
Vitale, A1
Leggiero, E1
Di Maio, A1
Barsotti, N1
Borello, U1
Napolitano, F1
Mandarino, A1
Carotenuto, M1
Heresco-Levy, U1
Pasqualetti, M1
Malatesta, P1
Gozzi, A1
Errico, F2
Salvatore, F1
Pastore, L1
Usiello, A2
Biundo, F1
d'Abramo, C1
Tambini, MD1
Zhang, H1
Del Prete, D1
Vitale, F1
Giliberto, L1
Arancio, O1
D'Adamio, L1
Shan, Y1
Jia, Y1
Zhong, S1
Li, X1
Zhao, H1
Chen, J1
Lu, Q1
Zhang, L2
Li, Z1
Lai, S1
Wang, Y1
Calderón-Garcidueñas, L1
Mora-Tiscareño, A1
Franco-Lira, M1
Zhu, H1
Lu, Z1
Solorio, E1
Torres-Jardón, R1
D'Angiulli, A1
Mazgaj, R1
Tal, A1
Goetz, R1
Lazar, M1
Rothman, K1
Messinger, JW1
Malaspina, D1
Gonen, O1
Jayaweera, HK1
Lagopoulos, J1
Duffy, SL1
Lewis, SJ1
Hermens, DF1
Norrie, L1
Hickie, IB1
Naismith, SL1
Yoon, KJ1
Lee, YT1
Chae, SW1
Park, CR1
Kim, DY1
Moon, CM1
Sundaram, T1
Choi, NG1
Jeong, GW1
Henry, LC1
Tremblay, S1
Boulanger, Y1
Ellemberg, D1
Lassonde, M1
Mantoan, MA1
Caboclo, LO1
de Figueiredo Ferreira Guilhoto, LM1
Lin, K1
da Silva Noffs, MH1
de Souza Silva Tudesco, I1
Belzunces, E1
Carrete, H1
Bussoletti, RT1
Centeno, RS1
Sakamoto, AC1
Yacubian, EM1
Kozora, E1
Brown, MS1
Filley, CM1
Miller, DE1
West, SG1
Pelzman, J1
Arciniegas, DB1
Bertolino, A1
Sciota, D1
Brudaglio, F1
Altamura, M1
Blasi, G1
Bellomo, A1
Antonucci, N1
Callicott, JH1
Goldberg, TE1
Scarabino, T1
Weinberger, DR1
Nardini, M1
Weiss, U1
Bacher, R1
Vonbank, H1
Kemmler, G1
Lingg, A1
Marksteiner, J1
Neylan, TC1
Lenoci, M1
Rothlind, J1
Metzler, TJ1
Schuff, N1
Du, AT1
Franklin, KW1
Weiss, DS1
Weiner, MW1
Marmar, CR1
Hanoğlu, L1
Ozkara, C1
Keskinkiliç, C1
Altin, U1
Uzan, M1
Tuzgen, S1
Dinçer, A1
Ozyurt, E1
Frederick, BD1
Lyoo, IK1
Satlin, A1
Ahn, KH1
Kim, MJ1
Yurgelun-Todd, DA1
Cohen, BM1
Renshaw, PF1
Metastasio, A1
Rinaldi, P1
Tarducci, R2
Mariani, E1
Feliziani, FT1
Cherubini, A1
Pelliccioli, GP2
Gobbi, G2
Senin, U2
Mecocci, P1
Hermann, D1
Sartorius, A1
Welzel, H1
Walter, S2
Skopp, G1
Ende, G2
Mann, K1
Charlton, RA1
McIntyre, DJ1
Howe, FA1
Morris, RG1
Markus, HS1
Nisticò, R1
Palma, G1
Federici, M1
Affuso, A1
Brilli, E1
Topo, E1
Centonze, D1
Bernardi, G1
Bozzi, Y1
D'Aniello, A1
Di Lauro, R1
Mercuri, NB1
Zimmerman, ME1
Pan, JW1
Hetherington, HP1
Katz, MJ1
Verghese, J1
Buschke, H1
Derby, CA1
Lipton, RB1
Parnetti, L1
Lowenthal, DT1
Presciutti, O1
Palumbo, R1
Chiarini, P1
Palumbo, B1
Raber, J1
Heim, C1
Zhang, J1
Lan, J1
Sieklucka, M1
Kurz, T1
Riederer, P1
Gerlach, M1
Sontag, KH1
Braus, DF1
Weber-Fahr, W1
Henn, FA1
Lin, A1
Nguy, CH1
Shic, F1
Ross, BD1
Abe, E1
Murai, S1
Masuda, Y1
Saito, H1
Itoh, T1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Functional Near Infrared Spectroscopy as a Biomarker of Response in Patients With Post-concussion Syndrome Treated With Transcranial Magnetic Stimulation[NCT04568369]91 participants (Actual)Interventional2020-05-02Active, not recruiting
An Open-label Exploratory Study With Memantine: Correlation Between Proton Magnetic Resonance Spectroscopy, Cerebrospinal Fluid Biomarkers, and Cognition in Patients With Mild to Moderate Alzheimer's Disease[NCT00551161]Phase 412 participants (Actual)Interventional2007-08-31Completed
Effects of Cannabidiol (CBD) on the Brain[NCT04831294]15 participants (Actual)Interventional2021-07-15Active, not recruiting
Promotion of Synaptic Plasticity With D-Aspartate to Favour Recovery Form Cerebral Damage[NCT03228524]Early Phase 1100 participants (Anticipated)Interventional2017-11-22Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Changes in the Metabolite Ratios of N-acetylaspartate (NAA) to Creatine (Cr), Myo-inositol (mI) to Cr, Choline (Cho) to Cr, NAA to Cho, and NAA to mI, on Cholinesterase Monotherapy vs Combination of Memantine and Cholinesterase Inhibitor

Ratios of myo-inositol (mI), N-acetylaspartate (NAA), total creatine (Cr), and choline (Cho) by single voxel 1H MRS (proton magnetic resonance spectroscopy). Mean (± SD) metabolite levels (normalized to T2-corrected water signal intensity) and metabolite ratios for Alzheimer's disease subjects at baseline (t0), after 24 weeks of ongoing monotherapy with stable-dose cholinesterase inhibitor (t1), and after another 24 weeks of combination therapy with memantine in addition to stable-dose cholinesterase inhibitor (t2). The Wilcoxon signed-rank test was used to examine whether the change between t0 and t1 differed from the change between t1 and t2 [(t2 - t1) - (t1 - t0)]. (NCT00551161)
Timeframe: Baseline, 24 weeks, and 48 weeks

Interventionratio (normalized to T2-corrected water (Mean)
Change in NAA [(t2-t1) - (t1-t0)]Change in Cr [(t2-t1) - (t1-t0)]Change in Cho [(t2-t1) - (t1-t0)]Change in mI [(t2-t1) - (t1-t0)]Change in NAA/Cr [(t2-t1) - (t1-t0)]Change in Cho/Cr [(t2-t1) - (t1-t0)]Change in mI/Cr [(t2-t1) - (t1-t0)]Change in NAA/Cho [(t2-t1) - (t1-t0)]Change in NAA/mI [(t2-t1) - (t1-t0)]
Memantine-54-2916-0.090.020.04-0.26-0.35

Reviews

1 review available for aspartic acid and Memory Disorders

ArticleYear
Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.
    Molecular neurobiology, 1998, Volume: 18, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adrenocorticotropic Hormone; Amygdala; Animals; Arginine Vasopre

1998

Trials

1 trial available for aspartic acid and Memory Disorders

ArticleYear
Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy.
    Toxicology letters, 2001, Sep-15, Volume: 123, Issue:2-3

    Topics: Administration, Oral; Adult; Aged; Aspartic Acid; Brain; Brain Chemistry; Choline; Creatine; Dimethy

2001

Other Studies

26 other studies available for aspartic acid and Memory Disorders

ArticleYear
Aspartic Acid-Modified Phospholipids Regulate Cell Response and Rescue Memory Deficits in APP/PS1 Transgenic Mice.
    ACS chemical neuroscience, 2022, 07-20, Volume: 13, Issue:14

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Aspartic Acid; Br

2022
D-aspartate oxidase gene duplication induces social recognition memory deficit in mice and intellectual disabilities in humans.
    Translational psychiatry, 2022, 08-01, Volume: 12, Issue:1

    Topics: Adult; Animals; Aspartic Acid; Autism Spectrum Disorder; D-Aspartate Oxidase; D-Aspartic Acid; Gene

2022
Abolishing Tau cleavage by caspases at Aspartate
    Translational psychiatry, 2017, 08-08, Volume: 7, Issue:8

    Topics: Animals; Aspartic Acid; Behavior, Animal; Brain; Caspases; Memory; Memory Disorders; Mice; Mice, Tra

2017
Correlations between working memory impairment and neurometabolites of prefrontal cortex and lenticular nucleus in patients with major depressive disorder.
    Journal of affective disorders, 2018, Volume: 227

    Topics: Adult; Aspartic Acid; Case-Control Studies; Choline; Corpus Striatum; Creatine; Depressive Disorder,

2018
Decreases in Short Term Memory, IQ, and Altered Brain Metabolic Ratios in Urban Apolipoprotein ε4 Children Exposed to Air Pollution.
    Journal of Alzheimer's disease : JAD, 2015, Volume: 45, Issue:3

    Topics: Adolescent; Age Factors; Air Pollution; Analysis of Variance; Apolipoprotein E4; Aspartic Acid; Brai

2015
Hypo-metabolism of the rostral anterior cingulate cortex associated with working memory impairment in 18 cases of schizophrenia.
    Brain imaging and behavior, 2016, Volume: 10, Issue:1

    Topics: Adult; Aging; Aspartic Acid; Creatine; Female; Gliosis; Gyrus Cinguli; Humans; Inositol; Intelligenc

2016
Spectroscopic markers of memory impairment, symptom severity and age of onset in older people with lifetime depression: Discrete roles of N-acetyl aspartate and glutamate.
    Journal of affective disorders, 2015, Sep-01, Volume: 183

    Topics: Aged; Aspartic Acid; Case-Control Studies; Cross-Sectional Studies; Depression; Female; Glutamic Aci

2015
Effects of anodal transcranial direct current stimulation (tDCS) on behavioral and spatial memory during the early stage of traumatic brain injury in the rats.
    Journal of the neurological sciences, 2016, Mar-15, Volume: 362

    Topics: Analysis of Variance; Animals; Aspartic Acid; Brain Edema; Brain Injuries, Traumatic; Brain-Derived

2016
Working memory dysfunction associated with brain functional deficits and cellular metabolic changes in patients with generalized anxiety disorder.
    Psychiatry research. Neuroimaging, 2016, Aug-30, Volume: 254

    Topics: Adult; Anxiety Disorders; Aspartic Acid; Brain; Brain Mapping; Case-Control Studies; Choline; Creati

2016
Neurometabolic changes in the acute phase after sports concussions correlate with symptom severity.
    Journal of neurotrauma, 2010, Volume: 27, Issue:1

    Topics: Acute Disease; Adult; Aspartic Acid; Athletic Injuries; Brain; Brain Concussion; Cognition Disorders

2010
Correlation between memory, proton magnetic resonance spectroscopy, and interictal epileptiform discharges in temporal lobe epilepsy related to mesial temporal sclerosis.
    Epilepsy & behavior : E&B, 2009, Volume: 16, Issue:3

    Topics: Adult; Aspartic Acid; Choline; Creatine; Epilepsy, Temporal Lobe; Female; Functional Laterality; Hum

2009
Memory impairment associated with neurometabolic abnormalities of the hippocampus in patients with non-neuropsychiatric systemic lupus erythematosus.
    Lupus, 2011, Volume: 20, Issue:6

    Topics: Adult; Aspartic Acid; Case-Control Studies; Creatine; Female; Glutamic Acid; Hippocampus; Humans; Lu

2011
Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder.
    The American journal of psychiatry, 2003, Volume: 160, Issue:3

    Topics: Adult; Aspartic Acid; Creatine; Female; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male;

2003
Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:3

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Brain Chemistry; Choline; Cognition Disorders; Creati

2003
Attention, learning, and memory in posttraumatic stress disorder.
    Journal of traumatic stress, 2004, Volume: 17, Issue:1

    Topics: Alcoholism; Anthropometry; Aspartic Acid; Attention; Hippocampus; Humans; Learning; Male; Memory Dis

2004
Correlation between 1H MRS and memory before and after surgery in mesial temporal lobe epilepsy with hippocampal sclerosis.
    Epilepsia, 2004, Volume: 45, Issue:6

    Topics: Adolescent; Adult; Aspartic Acid; Brain Mapping; Choline; Creatinine; Electroencephalography; Epilep

2004
In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:8

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspartic Acid; Brain Mapping; Case

2004
Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
    Neurobiology of aging, 2006, Volume: 27, Issue:7

    Topics: Aged; Amnesia; Aspartic Acid; Cerebral Cortex; Choline; Cognition Disorders; Creatine; Dementia; Dis

2006
Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users.
    Biological psychiatry, 2007, Jun-01, Volume: 61, Issue:11

    Topics: Adult; Alcohol Drinking; Aspartic Acid; Attention; Creatine; Globus Pallidus; Gyrus Cinguli; Hair; H

2007
The relationship between white matter brain metabolites and cognition in normal aging: the GENIE study.
    Brain research, 2007, Aug-20, Volume: 1164

    Topics: Aged; Aged, 80 and over; Aging; Aspartic Acid; Brain; Cognition; Cognition Disorders; Cross-Sectiona

2007
Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility.
    Molecular and cellular neurosciences, 2008, Volume: 37, Issue:2

    Topics: Animals; Aspartic Acid; Cognition; D-Aspartate Oxidase; Hippocampus; Long-Term Potentiation; Male; M

2008
Hippocampal neurochemistry, neuromorphometry, and verbal memory in nondemented older adults.
    Neurology, 2008, Apr-29, Volume: 70, Issue:18

    Topics: Aged; Aged, 80 and over; Aging; Aspartic Acid; Creatine; Female; Hippocampus; Humans; Magnetic Reson

2008
1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease.
    Journal of the American Geriatrics Society, 1996, Volume: 44, Issue:2

    Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Aspartic Acid; Brain Chemistry; Case-Control Stud

1996
Cerebral oligaemia episode triggers free radical formation and late cognitive deficiencies.
    The European journal of neuroscience, 2000, Volume: 12, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aspartic Acid; Carotid Stenosis; Cognition Disorders; Corpu

2000
The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study.
    Archives of general psychiatry, 2000, Volume: 57, Issue:10

    Topics: Adult; Aspartic Acid; Cell Death; Choline; Creatine; Electroconvulsive Therapy; Female; Hippocampus;

2000
Reversal by 3,3',5-triido-L-thyronine of the working memory deficit, and the decrease in acetylcholine, glutamate and gamma-aminobutyric acid induced by ethylcholine aziridinium ion in mice.
    Naunyn-Schmiedeberg's archives of pharmacology, 1992, Volume: 346, Issue:2

    Topics: Acetylcholine; Animals; Aspartic Acid; Aziridines; Behavior, Animal; Brain; Choline; gamma-Aminobuty

1992